ICVTS Click here for other ICVTS advertising opportunities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2009;9:626-629. doi:10.1510/icvts.2009.210492
© 2009 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Keiichi Ishida
Mizuho Imamaki
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Ishida, K.
Right arrow Articles by Miyazaki, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishida, K.
Right arrow Articles by Miyazaki, M.

Institutional report - Vascular thoracic

Mid-term results of surgery for chronic thromboembolic pulmonary hypertension

Keiichi Ishidaa,*, Masahisa Masudab, Hideo Tanakab, Mizuho Imamakia, Masayoshi Katsumataa, Takuto Maruyamaa and Masaru Miyazakia

a Division of Cardiovascular Surgery, Department of General Surgery, Graduate School of Medicine, Chiba University, Inohana 1-8-1 Chuo-ku, Chiba 260-0856, Japan
b Department of Cardiovascular Surgery, National Hospital Organization, Chiba Medical Center, Tsubakimori 4-1-2 Chuo-ku, Chiba 260-8606, Japan

*Corresponding author. Tel.: +81-43-226-2103; fax: +81-43-226-2552.

E-mail address: keiichi-ishida{at}pro.odn.ne.jp (K. Ishida).

Pulmonary thromboendarterectomy is an effective surgical treatment for chronic thromboembolic pulmonary hypertension (CTEPH). In this study, we review our short- and mid-term results in the recent series of patients undergoing pulmonary thromboendarterectomy. Twenty-three patients (54±12 years) were re-evaluated 7–59 months (mean, 34 months) after surgery. Nine patients were in New York Heart Association functional class II, 11 patients in class III and three patients in class IV. All patients used supplemental oxygen therapy. After surgery, pulmonary hemodynamics were significantly improved: pulmonary vascular resistance (PVR) decreased from 925±342 to 337±260 dynes·s·cm–5 (P<0.01); mean pulmonary artery pressure (MPAP) decreased from 47±12 to 25±10 mmHg (P<0.01). Three patients developed severe residual pulmonary hypertension and one of them died soon after surgery. During the follow-up period there were no deaths, but one recurrence of pulmonary embolism. Nineteen patients (86%) were in New York Heart Association functional class I or II and thirteen patients (59%) were weaned from oxygen therapy. In conclusion, pulmonary thromboendarterectomy provided remarkable early and late results with acceptable hospital mortality rate, normalization of pulmonary hemodynamics, and improvement in clinical functional status with relief of hypoxemia.

Key Words: Chronic thromboembolic pulmonary hypertension; Pulmonary hypertension; Pulmonary thromboendarterectomy; Surgical outcomes







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 European Association for Cardio-thoracic Surgery